Montelukast Prescribing at AMICUS HEALTH
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,160
Total Quantity
42.1K
NHS Cost
£2.0K
vs National Avg
+69.4%
AMICUS HEALTH prescribed 1,160 items of Montelukast over the last 12 months at a cost of £2,033 to the NHS. This is 69.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
98
Jun 2026
86
Jun 2026
94
Jun 2026
106
Jun 2026
103
Jun 2026
94
Jun 2026
100
Jun 2026
104
Jun 2026
112
Jun 2026
80
Jun 2026
100
Jun 2026
83
Prescribing Details
| Total Items | 1,160 |
|---|---|
| Total Quantity | 42,101 |
| Total NHS Cost | £2,033 |
| Presentations | 4 different forms |
| vs National Average | +69.4% |
Montelukast Prescribing Comparison
| This practice | 1,160 items |
|---|---|
| National average per practice | 685 items |
| Difference | +69.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.